Don't forget PFS understates the likely OS benefits when it comes to the antibody targeting.
Looking very likely that OS will again be shown to br almost 4x that of pluvicto.
Kick arse.
- Forums
- ASX - By Stock
- Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
Don't forget PFS understates the likely OS benefits when it...
-
-
- There are more pages in this discussion • 175 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
|
|||||
Last
$17.74 |
Change
0.300(1.72%) |
Mkt cap ! $5.936B |
Open | High | Low | Value | Volume |
$17.50 | $17.88 | $17.42 | $23.05M | 1.299M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 3775 | $17.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.74 | 1499 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3775 | 17.720 |
1 | 550 | 17.710 |
2 | 3338 | 17.700 |
1 | 178 | 17.680 |
2 | 1258 | 17.660 |
Price($) | Vol. | No. |
---|---|---|
17.740 | 1499 | 1 |
17.750 | 3948 | 2 |
17.810 | 1258 | 2 |
17.830 | 5362 | 1 |
17.840 | 439 | 1 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |